A Pivotal Trial to Establish the Efficacy and Safety of Algisyl in Patients With Moderate to Severe Heart Failure
Not Applicable
- Conditions
- Heart FailureDilated CardiomyopathyHeart Failure With Reduced Ejection Fraction
- Interventions
- Device: AlgisylDrug: Standard Medical Therapy
- First Posted Date
- 2017-03-17
- Last Posted Date
- 2017-03-17
- Lead Sponsor
- LoneStar Heart, Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT03082508
An Open Label Rollover Trial for Patients Randomized to the Control Group of Study LSH-10-001
Not Applicable
- Conditions
- CardiomyopathyHeart FailureDilated Cardiomyopathy
- Interventions
- Device: Algisyl-LVR
- First Posted Date
- 2014-08-27
- Last Posted Date
- 2014-08-27
- Lead Sponsor
- LoneStar Heart, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT02226679
- Locations
- 🇷🇴
Emergency Clinic Center of The Army for The Cardiovascular Diseases, Bucharest, Romania
🇮🇹A.O. Istituti Ospitalieri di Cremona"., Cremona, Italy
A Randomized, Controlled Study to Evaluate Algisyl-LVRâ„¢ as a Method of Left Ventricular Augmentation for Heart Failure
Phase 2
Completed
- Conditions
- Heart FailureDilated Cardiomyopathy
- Interventions
- Device: Algisyl-LVRDrug: Standard medical therapy
- First Posted Date
- 2011-03-10
- Last Posted Date
- 2017-03-15
- Lead Sponsor
- LoneStar Heart, Inc.
- Target Recruit Count
- 78
- Registration Number
- NCT01311791
- Locations
- 🇩🇪
Charité (Campus Virchov), Berlin, Germany
🇩🇪Universität Schleswig-Holstein Campus Kiel, Kiel, Germany
🇩🇪Charité - Universitätsmedizin Berlin (Campus Benjamin Franklin), Berlin, Germany
Safety and Feasibility of Algisyl-LVRâ„¢ as a Method of Left Ventricular Restoration in Patients With DCM Undergoing Open-heart Surgery
Phase 2
Completed
- Conditions
- Dilated Cardiomyopathy
- Interventions
- Device: Algisyl-LVR
- First Posted Date
- 2009-02-19
- Last Posted Date
- 2012-11-30
- Lead Sponsor
- LoneStar Heart, Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT00847964
- Locations
- 🇵🇱
John Paul II Hospital, Cracow, Poland
🇩🇪Heart Center of the Technical University of Dresden, Dresden, Germany
🇩🇪Deutsche Herzzentrum München, München, Bavaria, Germany
A Randomized Study to Demonstrate the Safety and Feasibility of Plexisyl-AF in Patients Undergoing Coronary Artery Bypass Grafting (CABG)
Not Applicable
Completed
- Conditions
- Atrial Fibrillation
- Interventions
- Device: Plexisyl-AFOther: No Treatment
- First Posted Date
- 2007-11-22
- Last Posted Date
- 2011-03-10
- Lead Sponsor
- LoneStar Heart, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT00562432
- Locations
- 🇩🇪
Herzzentrum Leipzig GmbH, Leipzig, Germany
🇩🇪Deutsches Herzzentrum München, Munich, Germany
🇩🇪Heart Center Dresden, Dresden, Germany
© Copyright 2025. All Rights Reserved by MedPath